BMP-2/-7 heterodimer, the most efficient stimulator of BMP signaling, diminishes the ALDHhi/CD44hi/CD24low CSC pool and effectively reduces the activation of TGF-β-driven SMAD signaling pathway, thereby inhibiting tumor invasion in breast cancer [95]. Here, BMP2 is linked to neoplasm.